Pregabalin may be added to reduce pain of fibromyalgia in patients who are taking antidepressants for comorbid depression, according to a study presented at the annual meeting of the American College of Rheumatology, held from Oct. 25 to 30 in San Diego.
Noting that it takes an average of 5 years before a fibromyalgia patient receives a diagnosis, researchers conducted a retrospective data analysis to identify significant variables that may enable earlier detection and diagnosis of fibromyalgia.
Fibromyalgia patients who don’t respond to Lyrica (pregabalin) may see their pain scores significantly improve after adding Savella (milnacipran) to their treatment regimens.
Some patients diagnosed with fibromyalgia may actually have small-fiber polyneuropathy (SFPN).
Occipital nerve stimulation (ONS) appears to be beneficial in fibromyalgia, with improvements seen in pain and quality of life, and is associated with alterations in activation patterns in areas involved in the cerebral pain matrix.
Female patients with fibromyalgia appear to be differentially sensitive to certain weather conditions rather than subject to a uniform influence of weather on daily pain and fatigue.